What Makes a Glutathione Supplement Different
JAMA 331 , 15191521 (2024)
Of those 161 patients, 16 (10%) experienced recurrent acute pancreatitis after GLP-1 receptor agonist therapy (mean duration 10.8 7.2 months): 6 (38%) were caused by the GLP-1 receptor agonist (as clinically determined by the treating medical team), three (18%) were due to hypertriglyceridemia, two (12%) due to alcohol use, one (6%) due to another oral hypoglycemic agent, one (6%) due to ampulla stenosis, and three (19%) were idiopathic
This is part of why fiber-rich diets are associated with better satiety and steadier energy
Many of them have been used in weight-loss teas, pills, and powders for decades, in some cases even longer than GLP-1 medications, yet they have never caused a true breakthrough in weight-loss treatment